Preliminary analysis of the melanoma multimedia educational program for general practitioners on behalf of the Italian Melanoma Intergroup


0
0
0
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Authors

  • Federica Zamagni Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy.
  • Fabio Falcini Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC); Cancer Prevention Unit, ASL Forlì, Forlì-Cesena, Italy.
  • Serena Magi Skin Cancer Unit, IRCCS IRST Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy. https://orcid.org/0000-0002-8082-336X
  • Lauro Bucchi Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy.
  • Silvia Mancini Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy. https://orcid.org/0000-0003-0673-3347
  • Rosa Vattiato Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy.
  • Emanuele Crocetti Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy. https://orcid.org/0000-0002-4649-2034
  • Stefano Falcinelli General Practitioner, district of Ravenna, AUSL Romagna, Ravenna, Italy.
  • Claudio Feliciani Division of Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy. https://orcid.org/0000-0003-0883-3210
  • Maurizio Lombardo Division of Dermatology, Department of Medicine and Surgery, Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese, Italy. https://orcid.org/0000-0002-9502-5133
  • Davide Melandri Division of Dermatology Cesena/Forlì AUSL Romagna and Department of Medicine and Surgery, University of Bologna, Italy. https://orcid.org/0000-0002-3746-308X
  • Maria Antonietta Pizzichetta Department of Dermatology, University of Trieste, Trieste; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Patrizia Re General Practitioner, district of Ravenna, AUSL Romagna, Ravenna, Italy.
  • Francesco Ricci IDI-IRCCS, Dermatological Research Hospital, Rome, Italy. https://orcid.org/0000-0002-8388-9268
  • Rosanna Rita Satta Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
  • Sara Gandini Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy. https://orcid.org/0000-0002-1348-4548
  • Ignazio Stanganelli Skin Cancer Unit, IRCCS IRST Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC); 5Division of Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • FAD MelaMEd Working Group Stefania Stucci, Marco Tucci (Bari), Vincenzo De Giorgi, Daniela Massi (Firenze), Paola Ghiorzo, Cesare Massone, Enrica Tanda (Genova), Francesco de Rosa, Matelda Medri (Meldola), Roberto Patuzzo (Milano), Corrado Caracò, Marco Palla (Napoli), Alessio Fabozzi (Padova), Mario Mandalà (Perugia), Riccardo Marconcini (Pisa), Paolo Fava, Elena Marra, Pietro Quaglino, Simone Ribero (Torino) for the development of educational contents; Anna Fanti, Fabiana Perrone, Rocco Tortorella (Parma), Barbara Andrea, Paolo Parente, Andrea Silenzi (Roma), Emanuela Manzato, Carlo Somenzi (Romagna), Gabriele Biondi, Chiara Musio, Giuseppe Palmieri (Sassari), Marco Paolo Donadini, Giovanna Scienza (Varese), for the organization at the local health unit level, Italy.

According to the National Oncological Plan 2023-2027 on the importance of multidisciplinary and interactive e-learning training, the Italian Melanoma Intergroup (IMI) has developed MelaMEd (Melanoma Multimedia Education), a national project for general practitioners (GPs) on the prevention and detection of cutaneous melanoma through an online platform and an online course. MelaMEd enables participants to i) recognize skin lesions that require specialist dermatological assessment, ii) select patients at high risk of melanoma and iii) be informed of the diagnosis and treatment pathway of patients with melanoma. A free online platform and online course were developed and launched in June 2022. Before starting the course, enrolled participants fill out a pre-training questionnaire concerning the basic knowledge of the disease and the recognition and management of suspicious lesions. After the course, participants will fill out the same questionnaire again. The online course will end in December 2023. Here we present a preliminary analysis of the pre-training results (January 2023-July 2023). The data have been analyzed descriptively. So far, five healthcare centers have participated in the project for a total of 1320 participants. Of these, 298 compiled the pre-training questionnaire. Forty-seven percent of them were aged <40 years. Respondents were almost divided between GPs (47%) and resident GPs (48%). Among the theoretical questions, the ABCDE rule and ugly duckling sign are well known (96% and 91% of correct answers, respectively), but a lower percentage (68%) of respondents knows the EFG rule for the recognition of nodular melanomas and the statement of Breslow thickness (29%). Regarding the series of clinical images of pigmented skin lesions and their management, the percentages rate of accuracy varied from 33% to 87%: melanoma (5 cases) ranges from 36% to 71%, melanocytic nevi (3 cases) from 33% to 84%, whereas the percentages rate of referral for dermatological evaluation varied from 44% to 99%. Melanoma cases referred to dermatologist ranges from 67% to 99%. This preliminary analysis on pre-training questionnaire mainly showed a lack of knowledge of the two major points of melanoma diagnosis (EFG) and management (Breslow thickness), as well as a low rate of participants. We will compare the proportions of correct answers to the questionnaires before and after the course once available.